Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Qian‐Ting Wang"'
Autor:
Ping Zhu, Shi-You Li, Jin Ding, Zhou Fei, Sheng-Nan Sun, Zhao-Hui Zheng, Ding Wei, Jun Jiang, Jin-Lin Miao, San-Zhong Li, Xing Luo, Kui Zhang, Bin Wang, Kun Zhang, Su Pu, Qian-Ting Wang, Xin-Yue Zhang, Gao-Liu Wen, Jun O. Liu, John Thomas August, Huijie Bian, Zhi-Nan Chen, You-Wen He
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 13, Iss 6, Pp 616-624 (2023)
Glioblastoma (GBM) is a lethal cancer with limited therapeutic options. Dendritic cell (DC)-based cancer vaccines provide a promising approach for GBM treatment. Clinical studies suggest that other immunotherapeutic agents may be combined with DC vac
Externí odkaz:
https://doaj.org/article/38ec1a088c2841dabe8481860dfceee9
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Dendritic cell (DC)-based vaccination is a promising immunotherapeutic strategy for cancer. However, clinical trials have shown only limited efficacy, suggesting the need to optimize protocols for human DC vaccine preparation. In this study, we syste
Externí odkaz:
https://doaj.org/article/2887f59b991642c888ab75cffbbe1742
Selected, peer reviewed papers from the 3rd international Conference on Manufacturing Science and Engineering (ICMSE 2012), March 27-29, 2012, Xiamen, China
Publikováno v:
Journal of Physical Organic Chemistry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fe9fc31b6f6746bac0387a84f36e864
https://doi.org/10.1002/poc.4516
https://doi.org/10.1002/poc.4516
Publikováno v:
ChemMedChem.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f6067d9b385860205728e6cd8a76836
https://doi.org/10.1002/cmdc.202200673
https://doi.org/10.1002/cmdc.202200673
Publikováno v:
Journal of Physical Organic Chemistry. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84d1d01a562bbbb3346f6a8b2f3ac044
https://doi.org/10.1002/poc.4474
https://doi.org/10.1002/poc.4474
Autor:
You-Wen He, Ping Zhu, Sheng-Nan Sun, Jin Ding, Zhao-Hui Zheng, Ding Wei, Jun Jiang, Jin-Lin Miao, San-Zhong Li, Zhou Fei, Kui Zhang, Bin Wang, Kun Zhang, Su Pu, Qian-Ting Wang, Xin-Yue Zhang, Gao-Liu Wen, Shi-You Li, Hui-Jie Bian, Zhi-Nan Chen, Jun Liu
Glioblastoma (GBM) is a lethal cancer with limited therapeutic options. Dendritic cell (DC)-based cancer vaccines represent a promising approach for GBM treatment. Clinical studies suggest that other immunotherapeutic agents including anti-PD-1 and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::754155570469c896f348104474828136
https://doi.org/10.21203/rs.3.rs-2199151/v1
https://doi.org/10.21203/rs.3.rs-2199151/v1
Autor:
Yong Li, Hua Yin, Sheng Nan Sun, Xiao Kai Guo, Shiyou Li, Yadong Wei, Ligong Lu, Jun Jiang, Meixiao Zhan, You-Wen He, Qian Ting Wang, Hui Zhang, Jun O. Liu
Publikováno v:
Hepatology. 73:821-832
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e052f40f2d37786aa27fb53f8429e0
https://doi.org/10.1002/hep.31502
https://doi.org/10.1002/hep.31502
Autor:
Shiyou Li, Hua Yin, Sheng Nan Sun, Qian Ting Wang, Yong Li, Ligong Lu, Jun Jiang, You-Wen He, Jun O. Liu, Xiao Kai Guo, Meixiao Zhan, Hui Zhang, Yadong Wei
Publikováno v:
Hepatology. 73:414-421
Hepatocellular carcinoma (HCC) is a major cause of cancer‐related death worldwide, accounting for 90% of liver cancers. Effective systemic treatments for advanced stage HCC are limited. The recent clinical application of mutated neoantigens as immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d941ea1453bcc3bdd4201a879269701
https://doi.org/10.1002/hep.31279
https://doi.org/10.1002/hep.31279
Autor:
Hui Zhang, Xiao Yunpeng, Jian Zhang, Hua-Xin Liao, Jun Jiang, Qian-Ting Wang, Li Junqi, You-Wen He, Xiaohui Yuan, Shiyou Li, Zhe Li, Yu-Ying Fan, Sheng-Nan Sun, Ming Zeng, Ru-Jin Han, Bin-Bin Zhao, Ying Nie, Tao Lin
Publikováno v:
Cancer Immunology, Immunotherapy. 69:1375-1387
Tumor-associated antigens (TAAs) have been tested in various clinical trials in cancer treatment but the patterns of specific T cell response to personalized TAA immunization remains to be fully understood. We report antigen-specific T cell responses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3005d50db631afc98b48e76193e17e0a
https://doi.org/10.1007/s00262-020-02496-w
https://doi.org/10.1007/s00262-020-02496-w